Researchers discover gene deletion associated with brain cancer
December 23, 2010
A University of Alabama at Birmingham study has identified a gene deletion in nearly 25 percent of all glioblastoma cases that is believed to be responsible for poor patient outcomes. The discovery could lead to better diagnosis and targeted treatments with drugs that are currently available.
Celebrex May Help Prevent Some Non-Melanoma Skin Cancers
New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.
Robotic surgery for head and neck cancer shows promise
December 21, 2010
Less-invasive robotic surgery for upper airway and digestive track malignant tumors is as effective as other minimally invasive surgical techniques based on patient function and survival, according to University of Alabama at Birmingham researchers.
UAB Comprehensive Cancer Center Director Named President of American Cancer Society
UAB Comprehensive Cancer Center Director Edward Partridge, M.D., a renowned women’s cancer doctor and leader in the fight to reduce race- and ethnicity-based cancer disparities, has been named president of the American Cancer Society (ACS) National Board of Directors for 2010-11.